Solanbridge Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SLNX research report →
Price Chart
About the company
Solanbridge Group, Inc. concentrates its efforts on cultivating and marketing medical cannabis in Nova Scotia, Canada. Additionally, the organization is committed to developing and distributing a range of CBD-enriched products throughout Nevada, California, and Colorado.
- CEO
- David J. Cutler
- IPO
- 2007
- HQ
- Lakewood, CO, US
Get TickerSpark's AI analysis on SLNX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $476.00K
- P/E
- -7.14
- PEG
- -0.07
- P/S
- 0.00
- P/B
- -5.31
- EV/EBITDA
- -7.03
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 118.24%
- ROIC
- 78.71%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-60
- Net Income
- $-67.75-95.5%
- EPS
- $0.00+0.0%
- OCF Growth
- +38.7%
- FCF Growth
- +38.7%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -6.84
- Avg Volume
- 1.23M
No earnings-call transcripts are available for SLNX yet.
No ownership data on file for SLNX.
Our SLNX coverage
Recent articles, reports, and earnings notes.
No research on SLNX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SLNX report →